Cartesian Therapeutics, Inc. RNAC Q1 2025 earnings

FAQ

When did Cartesian Therapeutics, Inc. report Q1 2025 earnings?

Cartesian Therapeutics, Inc. (RNAC) reported Q1 2025 earnings on May 8, 2025 before market open.

What were Cartesian Therapeutics, Inc.'s Q1 2025 revenue and EPS?

Cartesian Therapeutics, Inc. reported revenue of $1.1M and eps of $-0.68 for Q1 2025.

Did Cartesian Therapeutics, Inc. beat estimates in Q1 2025?

Revenue beat the consensus estimate of $687.5K by $412.5K. EPS missed the consensus estimate of $-0.61 by $0.07.

How did Cartesian Therapeutics, Inc.'s Q1 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 81.2% from $5.8M a year earlier and eps grew 65.5% from $-1.97.

Where can I find Cartesian Therapeutics, Inc.'s Q1 2025 SEC filings?

You can read the 8-K earnings release (0001453687-25-000084) and the 10-Q periodic report (0001453687-25-000085) directly on SEC EDGAR. The filing index links above go to sec.gov.